Moody’s affirms University of Maryland Medical System’s ‘A2’ rating

Moody’s Investors Service has affirmed the “A2” rating on Baltimore-based University of Maryland Medical System’s $1.1 billion of debt.

Advertisement

The rating affirmation is based on a number of factors, including UMMS’ strong leadership position and recent healthy financial performance.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that UMMS will continue to generate margins in line with recent performance.

More articles on healthcare finance:
28 hospitals, health systems seeking RCM talent
Physicians predict Brexit from Medicare under MACRA
4 key factors in a hospital’s financial turnaround plan

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.